Publications by authors named "Kevin Latinis"

Claim this Profile
B
Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.
Andrew A Welcher, Michael Boedigheimer, Alan J Kivitz, Zahir Amoura, Jill Buyon, Kevin Latinis

Arthritis Rheumatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
W Winn Chatham, Daniel J Wallace, William Stohl, Kevin M Latinis, Susan Manzi

J Rheumatol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.
William Stohl, Falk Hiepe, Kevin M Latinis, Mathew Thomas, Morton A Scheinberg

Arthritis Rheum· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza

Arthritis Rheum· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis

Arthritis Rheum· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.
Fabian A Mendoza, Carol M Artlett, Nora Sandorfi, Kevin Latinis, Sonsoles Piera-Velazquez

Semin Arthritis Rheum· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity.
Marina Cella, Keiko Fujikawa, Ilaria Tassi, Sunjin Kim, Kevin Latinis

J Exp Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.
Sergio A Jiménez, Carol M Artlett, Nora Sandorfi, Chris Derk, Kevin Latinis

Arthritis Rheum· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14. Immunologic rheumatic disorders.
Richard D Brasington, Leslie E Kahl, Prabha Ranganathan, Kevin M Latinis, Celso Velazquez

J Allergy Clin Immunol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis